Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07724834) titled 'CD19-B Cell Depletion in PAIS-ME/CFS Patients' on July 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Charite University, Berlin, Germany
Condition:
Post-acute Infectious Syndrome (PAIS)
Post-COVID 19 Condition (PCC or Long COVID)
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Intervention:
Drug: Inebilizumab
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: December 1, 2026
Targe...